Indegene's Strong Revenue Growth Masks Profitability Squeeze
Indegene's Q1 FY27 revenue jumped nearly 40% year-on-year, but net profit was flat as margins compressed sharply.
Indegene reported a 39.7% surge in quarterly revenue, yet profit remained virtually unchanged from last year. The net profit margin fell significantly, highlighting a profitability challenge.
Indegene's first quarter of FY27 presents a story of two diverging trends: impressive revenue growth coupled with a significant squeeze on profitability. While sales surged nearly 40% year-on-year, net profit was essentially flat, reflecting a sharp contraction in the company's net profit margin.
The digital life sciences company reported revenue of ₹1,063.1 crore for the quarter ended June 2026, a strong 5.9% sequential increase from the previous quarter. However, profit after tax (PAT) of ₹116.2 crore was virtually unchanged from the ₹116.4 crore earned in the same quarter last year. This resulted in a net profit margin of 10.9%, a substantial 440 basis point decline from the 15.3% margin in Q1 FY26.
A look at the last five quarters shows the evolving pressure on margins even as the revenue base has expanded consistently.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 1,063.1YoY +40% | 1,003.4 | 760.8 |
| Profit (₹ Cr) | 116.2YoY -0.2% | 79.7 | 116.4 |
| Net Profit Margin (%) | 10.9YoY -29% | 7.9 | 15.3 |
The quarter-on-quarter picture is more positive, with profit rebounding 45.8% from a weaker Q4. On a trailing twelve-month (TTM) basis, revenue stands at ₹3,812.8 crore with a PAT margin of 10.5%.
Key Points
- The company maintains a robust balance sheet with zero debt and a healthy interest coverage ratio of 28.2x.
- Return on Equity (RoE) for the period was 14.14%.
- The stock trades at a P/E of 26.1, a significant discount to the industry average P/E of 67.5.
For Indegene, the immediate challenge is clear: translating its formidable top-line momentum back into bottom-line growth. The coming quarters will reveal if this margin compression is a temporary phase of investment or a more persistent structural shift.
Live Chart
· INDGN
(BSE)
ISIN: INE065X01017
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.